BioCentury | Jul 25, 2019
Distillery Therapeutics

Innate Pharma's trifunctional NK cell engagers for multiple cancers

...France email: laurent.gauthier@innate-pharma.fr CONTACT: Eric Vivier, Innate Pharma, Marseille, France; Aix-Marseille University, Marseille, France email: vivier@ciml.univ-mrs.fr Sandi...
BioCentury | Dec 6, 2016
Distillery Therapeutics

Infectious disease

...Institut National de la Santé et de la Recherche Médicale, Aix-Marseille University, Marseille, France email: sieweke@ciml.univ-mrs.fr Steven...
BioCentury | Oct 22, 2012
Company News

DBV, Centre d'Immunologie de Marseille-Luminy (CIML) deal

...DBV partnered with the CIML to research the mechanism of action involved in DBV's epicutaneous immunotherapy...
...IIb trial, which is slated for completion in 1H14. DBV Technologies (Euronext:DBV), Bagneux, France Centre d'Immunologie de Marseille-Luminy (CIML...
BioCentury | Jan 26, 2012
Distillery Therapeutics

Indication: Infectious disease

...Ugolini, Aix-Marseille University, Marseille, France e-mail: ugolini@ciml.univ-mrs.fr Contact: Eric Vivier, same affiliation as above e-mail: vivier@ciml.univ-mrs.fr BC...
BioCentury | Jan 26, 2012
Targets & Mechanisms

Unleashing NK cells

...Ugolini, Aix-Marseille University, Marseille, France e-mail: ugolini@ciml.univ-mrs.fr Contact: Eric Vivier, same affiliation as above e-mail: vivier@ciml.univ-mrs.fr Lev...
BioCentury | Dec 3, 2009
Distillery Techniques

Technology: Drug platforms

...published online Nov. 6, 2009; doi:10.1126/science.1176056 Contact: Michael H. Sieweke, Aix-Marseille University, Marseille, France e-mail: sieweke@ciml.univ-mrs.fr BC...
BioCentury | Feb 5, 2009
Distillery Therapeutics

Indication: Autoimmune disease

...26, 2009; doi:10.1073/pnas.0811073106 Contact: Philippe Pierre, University of the Mediterranean Aix-Marseille II, Marseille, France e-mail: pierre@ciml.univ-mrs.fr BC...
BioCentury | Dec 22, 2003
Company News

Pamgene scientific advisory board update

...PamGene B.V. , Hertogenbosch, the Netherlands Business: Microarrays Appointed: Bertrand Jordan, retired director of CIML; Daniel...
Items per page:
1 - 8 of 8
BioCentury | Jul 25, 2019
Distillery Therapeutics

Innate Pharma's trifunctional NK cell engagers for multiple cancers

...France email: laurent.gauthier@innate-pharma.fr CONTACT: Eric Vivier, Innate Pharma, Marseille, France; Aix-Marseille University, Marseille, France email: vivier@ciml.univ-mrs.fr Sandi...
BioCentury | Dec 6, 2016
Distillery Therapeutics

Infectious disease

...Institut National de la Santé et de la Recherche Médicale, Aix-Marseille University, Marseille, France email: sieweke@ciml.univ-mrs.fr Steven...
BioCentury | Oct 22, 2012
Company News

DBV, Centre d'Immunologie de Marseille-Luminy (CIML) deal

...DBV partnered with the CIML to research the mechanism of action involved in DBV's epicutaneous immunotherapy...
...IIb trial, which is slated for completion in 1H14. DBV Technologies (Euronext:DBV), Bagneux, France Centre d'Immunologie de Marseille-Luminy (CIML...
BioCentury | Jan 26, 2012
Distillery Therapeutics

Indication: Infectious disease

...Ugolini, Aix-Marseille University, Marseille, France e-mail: ugolini@ciml.univ-mrs.fr Contact: Eric Vivier, same affiliation as above e-mail: vivier@ciml.univ-mrs.fr BC...
BioCentury | Jan 26, 2012
Targets & Mechanisms

Unleashing NK cells

...Ugolini, Aix-Marseille University, Marseille, France e-mail: ugolini@ciml.univ-mrs.fr Contact: Eric Vivier, same affiliation as above e-mail: vivier@ciml.univ-mrs.fr Lev...
BioCentury | Dec 3, 2009
Distillery Techniques

Technology: Drug platforms

...published online Nov. 6, 2009; doi:10.1126/science.1176056 Contact: Michael H. Sieweke, Aix-Marseille University, Marseille, France e-mail: sieweke@ciml.univ-mrs.fr BC...
BioCentury | Feb 5, 2009
Distillery Therapeutics

Indication: Autoimmune disease

...26, 2009; doi:10.1073/pnas.0811073106 Contact: Philippe Pierre, University of the Mediterranean Aix-Marseille II, Marseille, France e-mail: pierre@ciml.univ-mrs.fr BC...
BioCentury | Dec 22, 2003
Company News

Pamgene scientific advisory board update

...PamGene B.V. , Hertogenbosch, the Netherlands Business: Microarrays Appointed: Bertrand Jordan, retired director of CIML; Daniel...
Items per page:
1 - 8 of 8